![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
X
20
Remel Inc Lenexa Us, based in U.S.A, is a pharmaceutical company.
One of their significant offerings is Blood Agar, (Tryptic Soy Agar with 5% Sheep Blood; Product codes: 01198, 01200, 01201 and 01202), supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2001-192 - Rev 00
This TSE Type CEP, issued on February 13, 2008, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.